These data are supported by current research, which has shown that IL-6 increases the uncoupling protein 1 (UCP1) expression in WAT, in gastric and CRC patients, with UCP1-positive cells being mainly detected in advanced cancer stages [52]. This evidence concerns the gene IL6 and cancer.